Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study on Changes in Sleep Apnea Among Patients With Type 2 Diabetes/Obesity and Comorbid OSA After Short-Term Treatment With Semaglutide

NCT07281196 is registered in ClinicalTrials.gov with Shanghai Fengxian District Central Hospital as lead sponsor.

NCT NCT07281196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07281196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study on Changes in Sleep Apnea Among Patients With Type 2 Diabetes/Obesity and Comorbid OSA After Short-Term Treatment With Semaglutide
Lead sponsor
Shanghai Fengxian District Central Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2025
Completion date
January 31, 2026
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep apnea syndrome (osas)